ArticleArthritis research & therapy2025

Serum CXCL6 as a biomarker for diagnosing and predicting progression of interstitial lung disease in ANCA-associated vasculitis.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.